Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Healthcare

    Tag: healthcare

    You Searched For "Healthcare"
    Healthians launches operations in Maharashtra; plans to infuse over Rs 34 crore to expand services

    Healthians launches operations in Maharashtra; plans to infuse over Rs 34 crore to expand services

    Medical Dialogues Bureau9 Jun 2019 9:40 AM IST
    Healthians is looking for more acquisitions to fuel its aggressive growth plans and plans to invest over USD 5 million to expand its services to...
    GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma

    GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma

    Medical Dialogues Bureau8 Jun 2019 10:00 AM IST
    The price tag for the mainly Europe-focused brand portfolio, which includes itch relief cream Eurax, antiseptic cream Savlon and Tixylix cough...
    Healthcare Startup Pristyn Care raises Rs 27 crore funding from Sequoia India

    Healthcare Startup Pristyn Care raises Rs 27 crore funding from Sequoia India

    Medical Dialogues Bureau5 Jun 2019 2:36 PM IST
    New Delhi: Healthcare delivery startup Pristyn Care Monday said it has raised USD 4 million (about Rs 27.7 crore) in funding from Sequoia...
    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    Farhat Nasim4 Jun 2019 5:44 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Cadila Healthcare gets 11 USFDA observations for St Louis facilities

    Cadila Healthcare gets 11 USFDA observations for St Louis facilities

    Farhat Nasim3 Jun 2019 5:23 PM IST
    The United States Food and Drug Administration (USFDA) inspected the manufacturing facilities of Nesher Pharmaceuticals (USA) LLC located at St Louis,...
    Roche, GE Healthcare launch NAVIFY Tumor Board to enable personalised treatment decisions in cancer care

    Roche, GE Healthcare launch NAVIFY Tumor Board to enable personalised treatment decisions in cancer care

    Medical Dialogues Bureau3 Jun 2019 9:45 AM IST
    The new version of NAVIFY Tumor Board is initially available in the United States and Canada with additional markets to follow in the near future.New...
    GSK Consumers Healthcare gets shareholders

    GSK Consumers Healthcare gets shareholders' nod for merger with HUL

    Medical Dialogues Bureau3 Jun 2019 9:30 AM IST
    Earlier in January, GlaxoSmithKline (GSK) Consumer Healthcare had informed that it has received approval from the fair trade regulator CCI for its...
    Medikabazaar to raise Rs 200 crore in Series B funding

    Medikabazaar to raise Rs 200 crore in Series B funding

    Garima29 May 2019 9:30 AM IST
    This is being done as part of the Medikabazaar's growth and expansion plans to clock in $100 million in revenues in the financial year 2019-20, he...
    GSK, Pfizer gets CCI approval for consumer healthcare JV formation

    GSK, Pfizer gets CCI approval for consumer healthcare JV formation

    Garima25 May 2019 9:45 AM IST
    After the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business, while Pfizer will...
    GSK reintroduce incentives for sales representatives

    GSK reintroduce incentives for sales representatives

    Farhat Nasim24 May 2019 9:31 AM IST
    GSK said it would make changes to its incentive program for pharmaceutical and vaccines sales representatives, to be applied initially in the United...
    Fortis investors move SEBI over delay in IHH open offer, ask for interest: Report

    Fortis investors move SEBI over delay in IHH open offer, ask for interest: Report

    Meghna A Singhania23 May 2019 5:22 PM IST
    New Delhi: Displeased with delay in an open offer to buy an additional stake, a few of the shareowners holding minor shares of Fortis Healthcare Ltd...
    Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin

    Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin

    Farhat Nasim23 May 2019 11:59 AM IST
    Ogivri is the first trastuzumab biosimilar approved in Canada and the second biosimilar from Biocon and Mylan's joint portfolio approved in the...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok